Rochester, NY, United States of America

Rajiv P Balasubramaniam


Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 72(Granted Patents)


Location History:

  • Rochester, NY (US) (1998 - 1999)
  • Davis, CA (US) (1999)

Company Filing History:


Years Active: 1998-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rajiv P Balasubramaniam: Innovator in Biochemical Formulations

Introduction

Rajiv P Balasubramaniam is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of biochemical formulations, particularly in the area of cytofectins. With a total of 3 patents to his name, his work has implications for the transfection of cells, which is crucial in various biomedical applications.

Latest Patents

His latest patents include formulations and methods for generating active cytofectin. These formulations involve the generation of cytofectin:polynucleotide complexes for the transfection of cells. The methods maximize transfection by utilizing a cationic amine compound with specific structural characteristics. Additionally, he has developed polyfunctional cationic cytofectins for transporting biologically active species through membrane barriers, showcasing his innovative approach to biochemical challenges.

Career Highlights

Rajiv is affiliated with the University of California, where he continues to advance research in his field. His work is characterized by a focus on enhancing the efficiency of cellular transfection methods, which has the potential to impact gene therapy and other medical applications.

Collaborations

Some of his notable coworkers include Michael H Nantz and Michael J Bennett, who have collaborated with him on various projects, contributing to the advancement of their shared research interests.

Conclusion

Rajiv P Balasubramaniam stands out as an influential inventor in the realm of biochemical formulations. His innovative patents and ongoing research efforts continue to pave the way for advancements in cellular transfection technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…